KEGG analysis results show that the targets of the 6 molecules in the treatment of AD are significantly enriched in the Prolactin signaling pathway, Pathways in cancer, neuroactive ligand-receptor interaction, and L-17 signaling pathway. The gene discussed is PRL; the disease is cancer.